Host Conditions Affecting the Course of Coxsackievirus Infections

  • Roger M. Loria
Part of the Infectious Agents and Pathogenesis book series (IAPA)


A search of the literature showed that specific review articles on host conditions affecting viral infection or specifically group coxsackievirus (CV) infection could not be found in the major data bases. Consequently, the reader is referred to general reviews on group CV and/or enteroviruses for additional details.1–8 The paucity of reviews in this area is indicative of a general trend that has emphasized the role of the infectious agent and minimized the importance of the interaction between the host and the infecting virus.


Aseptic Meningitis Host Condition Islet Cell Antibody Coxsackie Virus Rickettsial Infection 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kibrick, S., 1964, Current status of Coxsackie and Echo viruses in human disease, Prog. Med. Virol. 6:27–70.PubMedGoogle Scholar
  2. 2.
    Melnick, J. L., 1985, Enteroviruses: Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, in: Virology (B. N. Fields, D. N. Knipe, R. M. Chanock, J. L. Melnick, R. M. Roizman, and R. E. Shope, eds.) pp. 739–794, Raven, New York.Google Scholar
  3. 3.
    Cherry, J. D., 1983, Enteroviruses, in: Infectious Diseases of the Fetus and Newborn Infant (J. S. Remington and J. D. Klein, eds.), pp. 290–334, WB Saunders, Philadelphia.Google Scholar
  4. 4.
    Mims, C. A., 1982, Hot and microbial factors influencing susceptibility, in: The Pathogenesis of Infectious Disease, 2nd ed. (C. A. Mims, ed.), pp. 237–258, Academic, New York.Google Scholar
  5. 5.
    Buddingh, J. G., 1965, Pathogenesis and pathology of viral infections, in: Viral and Rickettsial Infection of Man, 4th ed. (F. L. Horsfall and E. Tamm, eds.), pp. 339–355, JB Lippincott, Philadelphia.Google Scholar
  6. 6.
    Platt, H., 1965, Pathogenesis, in: Viral and Rickettsial Infections of Animals (A. O. Betts and C.J. York, eds.), pp. 167–210, Academic, New York.Google Scholar
  7. 7.
    Beveridge, W. I. B., 1965, Epidemiology of virus diseases, in: Viral and Rickettsial Infections of Animals (A. O. Betts and C. J. York, eds.), pp. 335–364, Academic, New York.Google Scholar
  8. 8.
    White, D. O., and Fenner, F. J., 1986, Medical Virology, pp. 119–145, Academic Press, New York.Google Scholar
  9. 9.
    Huppert, J., and Wild, T. F., 1984, Virus disease without a virus, Ann. Virol. 135:327–333.Google Scholar
  10. 10.
    Loria, R. M., Montgomery, L. B., Corey, L. A., and Chinchilli, V., 1984, Coxsackie virus B4 infection in animals with diabetes mellitus genotype, Arch. Virol. 81:251–262.PubMedCrossRefGoogle Scholar
  11. 11.
    Johnson, T., 1954, Family infections by Coxsackie viruses, Arch. Ges. Virusforsch. 5:384–400.CrossRefGoogle Scholar
  12. 12.
    Kaplan, A. S., and Melnick, J. L., 1951, Oral administration of Coxsackie viruses to newborn and adult mice, Proc. Soc. Exp. Biol. Med. 76:312–315.PubMedGoogle Scholar
  13. 13.
    Bang, F. B., and Luttrell, C. N., 1961, Factors in the pathogenesis of virus disease, in: Advances in Virus Research, Vol. 8 (K. N. Smith and M. A. Lauffer, eds.), pp. 199–244, Academic, New York.Google Scholar
  14. 14.
    Maximovich, N. A., and Suptel, E. A., 1966, Changes caused by and multiplication of virus Coxsackie in tissue of susceptible animals, Acta Virol. 10:425–429.PubMedGoogle Scholar
  15. 15.
    Hable, K. A., O’Connel, E. J., and Herrmann, E. C., 1970, Group B Coxsackieviruses as respiratory viruses, Mayo Clin. Proc. 45:170–177.PubMedGoogle Scholar
  16. 16.
    Lycke, E., 1983, General aspects of pathogenesis of virus infections, in: Textbook of Medical Virology (E. Lycke and E. Norrby, eds.), pp. 112–124, Butterworths, London.Google Scholar
  17. 17.
    Magee, W. E., and Miller, O. V., 1970, Individual variability in antibody response of human volunteers to infection of the upper respiratory tract by Coxsackie A-21 virus, J. Infect. Dis. 122:127–138.PubMedCrossRefGoogle Scholar
  18. 18.
    Gevaudan, P., and Charrel, J., 1963, Etude de la virémie expérimentale de la souris adulte après ingestion de virus C., C. R. Soc. Biol. 162:2232–2237.Google Scholar
  19. 19.
    Gevaudan, P., and Charrel, J., 1964, Infection expérimentale de la souris adulte par ingestion de virus Coxsackie. Chéminement du virus au cours des phases pré et postvirimiques, C. R. Soc. Biol. 158:2387–2390.Google Scholar
  20. 20.
    Loria, R. M., Kibrick, S., and Broitman, S. A., 1974, Peroral infection with group B coxsackievirus in the newborn mouse,J. Infect. Dis. 130:225–230.PubMedCrossRefGoogle Scholar
  21. 21.
    Loria, R. M., Kibrick, S., and Broitman, S. A., 1974, Peroral infection with group B coxsackievirus in the adult mouse: Protective function of the gut, J. Infect. Dis. 130:539–543.PubMedCrossRefGoogle Scholar
  22. 22.
    Loria, R. M., Shadoff, N., Kibrick, S., and Broitman, S. A., 1976, Maturation of intestinal defenses against peroral infection with group B coxsackievirus in the mouse, Infect. Immun. 13:1397–1401.PubMedGoogle Scholar
  23. 23.
    Boring, W. D., Zurhein, G. M., and Walker, D. L., 1956, Factors influencing host virus interactions. II. Alteration of coxsackievirus infection in adult mice by cold, Proc. Soc. Exp. Biol. Med. 93:273–277.PubMedGoogle Scholar
  24. 24.
    Gevaudan, P., and Charrel, J., 1966, Influence de la temperature sur l’volution de l’infection expérimentale du souriceau nouveaux-né par le virus Coxsackie, C. R. Soc. Biol. 160:139–141.Google Scholar
  25. 25.
    Gevaudan, P., Charrel, J., and Sautet, G., 1965, Psychrosensibilité de la souris maie à l’infection par le virus Coxsackie, C. R. Soc. Biol. 159:1188–1191.Google Scholar
  26. 26.
    Gevaudan, P., and Charrel, J., 1966, Effet favorable de l’hypothermie relative sur l’évolution de la maladie du souriceau nouveau-né inoculé par un variant chaud de virus Coxsackie, C. R. Soc. Biol. 160:820–826.Google Scholar
  27. 27.
    Teisner, B., and Haahr, S., 1974, Poikilothermia and susceptibility of suckling mice to Coxsackie Bl virus, Nature (Lond.) 247:568.CrossRefGoogle Scholar
  28. 28.
    Haahr, S., and Teisner, B., 1973, The influence of different temperatures on mortality, virus multiplication and interferon production in adult mice infected with CVB1, Arch. Ges. Virusforsch. 42:273–277.PubMedCrossRefGoogle Scholar
  29. 29.
    Jordan, G. W., and Bolton, V., 1985, Interferon-sensitive coxsackievirus variant in nature,J. Interferon Res. 5:289–296.PubMedCrossRefGoogle Scholar
  30. 30.
    Gauntt, C. J., Paque, R. E., Trousdale, M. D., Gudvangen, R. J., Barr, D. T., Lipotich, G. J., Nealon, T. J., and Duffey, P. S., 1983, Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis, Infect. Immun. 39:851–864.PubMedGoogle Scholar
  31. 31.
    Sigel, M. M., 1952, Influence of age on susceptibility to virus infection with particular reference to laboratory animals, Annu. Rev. Microbiol. 6:247–280.PubMedCrossRefGoogle Scholar
  32. 32.
    Gifford, R., and Dalldorf, G., 1951, The morbid anatomy of experimental Coxsackie virus infection, Am. J. Pathol. 27:1047–1064.PubMedGoogle Scholar
  33. 33.
    Howes, D. W., 1954, Studies of Coxsackie viruses. I. Comparison of age-susceptibility relationships in mice, Aust. J. Exp. Biol. Med. Sci. 32:253–264.PubMedCrossRefGoogle Scholar
  34. 34.
    Burnstein, T., 1960, Relative susceptibility of young mice and hamsters to Coxsackie B-3 virus, Proc. Soc. Exp. Biol. Med. 105:306–308.PubMedGoogle Scholar
  35. 34a.
    Melnick, J. L., and Curnen, E. C., 1952, The Coxsackie virus group, in: Viral and Rickettsial Infections of Man, 2 Ed., (T. M. Rivers, ed.), p. 342. J. P. Lippincott, Philadelphia.Google Scholar
  36. 35.
    Dalldorf, G., 1955, The Coxsackie viruses, Annu. Rev. Microbiol. 9:277–296.PubMedCrossRefGoogle Scholar
  37. 36.
    Hotchin, J. E., Weigand, H., and Benson, L. M., 1960, Immunological tolerance and virus infection with lymphocytic choriomeningitis in mice, Fed. Proc. 19:196 (abst).Google Scholar
  38. 37.
    Heineberg, H., Gold, E., and Robbins, F. C., 1964, Difference in interferon content in tissue of mice of various ages infected with Coxsackie B-1 virus, Proc. Soc. Exp. Biol. Med. 115:947–953.PubMedGoogle Scholar
  39. 38.
    Rytel, M. W., 1969, Interferon response during Coxsackie B-3 infection in mice. I. The effect of cortisone, J. Infect. Dis. 120:379–382.PubMedCrossRefGoogle Scholar
  40. 39.
    Berkovich, S., and Ressel, M., 1965, Effect of gonadectomy on susceptibility of the adult mouse to Coxsackie Bl virus infection, Proc. Soc. Exp. Biol. Med. 119:690–694.PubMedGoogle Scholar
  41. 40.
    Berkovich, S., and Ressel, M., 1967, Effect of sex on susceptibility of adult mice to Coxsackie Bl virus infection. Arch. Ges. Virusforsch. 22:246–251.CrossRefGoogle Scholar
  42. 41.
    Sabin, A. B., and Ward, R., 1941, The natural history of human poliomyelitis. I. Distribution of virus in the nervous and nonnervous tissues,J. Exp. Med. 73:771–793.PubMedCrossRefGoogle Scholar
  43. 42.
    Kunin, C. M., 1962, Virus-tissue union and the pathogenesis of enterovirus infections,J. Immunol. 88:556–569.PubMedGoogle Scholar
  44. 43.
    Crowell, R. L., 1976, Comparative generic characteristics of Picornavirus receptor interaction, in: Cell Membrane Receptors for Viruses, Antigens and Antibodies, Polypeptides, Hormones, and Small Molecules. (R. F. Beers and E. G. Basset, eds.), pp. 179–203, Raven Press, New York.Google Scholar
  45. 44.
    Grodums, E. I., and Dempster, G., 1959, The age factor in experimental Coxsackie B-3 infection, Can. J. Microbiol. 5:595–604.PubMedCrossRefGoogle Scholar
  46. 45.
    Grodums, E. I., and Dempster, G., 1959, Myocarditis in experimental Coxsackie B-3 infection, Can. J. Microbiol. 5:605–615.PubMedCrossRefGoogle Scholar
  47. 46.
    Grodums, E. I., and Dempster, G., 1962, Pathogenesis of Coxsackie group B viruses in experimental infection, Can. J. Microbiol. 8:105–113.PubMedCrossRefGoogle Scholar
  48. 47.
    Khatib, R., Chason, J. L., Silberberg, B. K., and Lerner, M. A., 1980, Age-dependent pathogenicity of group B coxsackieviruses in Swiss-Webster mice: Infectivity for myocardium and pancreas,J. Infect. Dis. 141:394–403.PubMedCrossRefGoogle Scholar
  49. 48.
    Hornberger, E., and Plotkin, S., 1983, Human skin fibroblasts are nonpermissive to Coxsackie B4 infection: An age dependent phenomenon, Intervirology 19:195–200.PubMedCrossRefGoogle Scholar
  50. 49.
    Morag, A., Margalit, M., Shuval, H. I., and Fattal, B., 1984, Acquisition of antibodies to various Coxsackie and Echo viruses and hepatitis A virus in agricultural communal settlements in Israel,J. Med. Virol. 14:39–47.PubMedCrossRefGoogle Scholar
  51. 50.
    Noah, N. D., and Urquhart, A. M., 1980, Virus meningitis and encephalitis in 1979,J. Infect. 2:379–383.PubMedCrossRefGoogle Scholar
  52. 51.
    Kaplan, M. H., Klein, S. W., McPhee, J., and Harper, R. G., 1983, Group B coxsackievirus infections in infants younger than three months of age: A serious childhood illness, Rev. Infect. Dis. 5:1019–1032.PubMedCrossRefGoogle Scholar
  53. 52.
    Rosenberg, H. S., Kohl, S., and Vogler, C., 1981, Viral infections of the fetus and the neonate, Monog. Pathol. 22:133–200.Google Scholar
  54. 53.
    Gear, J. H. S., and Measroch, V., 1973, Coxsackie virus infections of the newborn, Prog. Med. Virol. 15:42–62.PubMedGoogle Scholar
  55. 54.
    deSa, D. J., 1986, Isolated myocarditis as a cause of sudden death in the first year of life, Forensic Sci. Int. 30:113–117.PubMedCrossRefGoogle Scholar
  56. 55.
    Jenista, J. A., Powell, K. R., and Menegus, M. A., 1984, Epidemiology of neonatal enterovirus infection.J. Pediatr. 104:685–690.PubMedCrossRefGoogle Scholar
  57. 56.
    Chamberlain, R. N., Christie, P. N., Holt, K. S., Huntley, R. M., Pollard, R., and Roche, M. C., 1983, A study of school children who had identified virus infections of the central nervous system during infancy, Child Care Health Dev. 9:29–47.PubMedCrossRefGoogle Scholar
  58. 57.
    King, M. L., Shaikh, A., Bidwell, D., Voller, A., and Banatvala, J. E., 1983, Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus, Lancet 1:1397–1399.PubMedCrossRefGoogle Scholar
  59. 58.
    Dalldorf, G., and Gilford, R., 1954, Susceptibility of gravid mice to Coxsackie virus infection,J. Exp. Med. 99:21–27.PubMedCrossRefGoogle Scholar
  60. 59.
    Surjus, A., 1961, Effet du virus Coxsackie B3 sur la souris gestante et sa transmission transplacentaire, Ann. Inst. Pasteur 100:825–827.Google Scholar
  61. 60.
    Meyer, J., and Loffler, H., 1968, Infektin gravider Mäuse mit coxsackievirus, Pathol. Microbiol. 32:139–140.Google Scholar
  62. 61.
    Reyes, M. P., Zalenski, D., Smith, F., Wilson, F. M., and Lerner, M. A., 1986, Cox-sackievirus-positive cervices in women with febrile illnesses during the third trimester in pregnancy, Am. J. Obstet. Gynecol. 155:159–161.PubMedGoogle Scholar
  63. 62.
    Baker, D. A., and Philips, C. A., 1980, Maternal and neonatal infection with coxsackievirus, Obstet. Gynecol. 55:128–158.CrossRefGoogle Scholar
  64. 63.
    Kibrick, S., and Benirscke, K., 1958, Severe generalized disease (encephalohep-tomyocarditis) occurring in the newborn period due to infection with Coxsackie virus group B, Pediatrics 22:857–875.PubMedGoogle Scholar
  65. 64.
    Lansdown, A. B., 1977, Coxsackievirus B3 infection in pregnancy and its influence on fetal heart development, Br. J. Exp. Pathol. 58:378–385.PubMedGoogle Scholar
  66. 65.
    Lansdown, A. B., 1978, Viral infections and disease of the heart, Prog. Med. Virol. 24:70–113.PubMedGoogle Scholar
  67. 66.
    Lansdown, A. B., 1977, Histological observations on thymic development in fetal and newborn mammals subject to intrauterine growth retardation, Biol. Neonate 31:252–259.PubMedCrossRefGoogle Scholar
  68. 67.
    Brown, G. C., 1970, Maternal virus infection and congenital anomalies, Arch. Environ. Health 21:362–365.PubMedGoogle Scholar
  69. 68.
    Brown, G. C., 1966, Recent advances in the viral aetiology of congenital anomalies, Adv. Teratol. 1:55–80.Google Scholar
  70. 69.
    Brown, G. C., 1968, Coxsackie virus infections and heart disease, Am. Heart J. 75:145–146.PubMedCrossRefGoogle Scholar
  71. 70.
    Brown, G. C., and Karunas, R. S., 1972, Relationship of congenital anomalies and maternal infection with selected enteroviuses, Am. J. Epidemiol. 95:207–217.PubMedGoogle Scholar
  72. 71.
    Hanshaw, J. B., and Dudgeaon, J. A., 1978, Viral Diseases of the Fetus and Newborn, WB Saunders, Philadelphia.Google Scholar
  73. 72.
    Hall, J. G., and Reed, S. D., 1982, Teratigens associated with congenital contractures in humans and in animals, Teratology 25:173–191.PubMedCrossRefGoogle Scholar
  74. 73.
    Drachman, D. B., Weiner, L. W., Price, D. L., and Chase, J., 1976, Experimental Arthrogryposis caused by viral myopathy, Arch. Neurol. 33:362–367.PubMedCrossRefGoogle Scholar
  75. 74.
    Koskimies, O., Lapinleimu, K., and Saxen, L., 1978, Infections and other maternal factors as risk indicators for congenital malformations: A case-control study with paired serum samples, Pediatrics 61:832–837.PubMedGoogle Scholar
  76. 75.
    Taina, E., Hanninen, P., and Gronroos, M., 1985, Viral infections in pregnancy, Acta Obstet. Gynecol. Scand. 64:167–73.PubMedCrossRefGoogle Scholar
  77. 76.
    Modlin, J. F., and Crumpacker, C. S., 1982, Coxsackievirus B infection in pregnant mice and transplacental infection of the fetus, Infect. Immun. 37:222–226.PubMedGoogle Scholar
  78. 77.
    Miranda, Q. R., Kirk, R. S., and Beswick, T. S. L., 1972, The long term effects of neonatal Coxsackie B5 infection in mice: Reduced fecundity of recovered females,J. Pathol. 109:183–193.CrossRefGoogle Scholar
  79. 78.
    Gauntt, C. J., Huntington, H. W., Arizpe, H. M., Gutvangen, R. J., and Deshambo, R. M., 1984, Murine forebrain anomalies induced by coxsackievirus B3 variants,J. Med. Virol. 14:341–355.PubMedCrossRefGoogle Scholar
  80. 79.
    Soike, K., 1967, Coxsackie B3 virus infection in the pregnant mouse,J. Infect. Dis. 117:203–208.PubMedCrossRefGoogle Scholar
  81. 80.
    Selzer, G., 1969, Transplacental infection of the mouse fetus by Coxsackie viruses, Israel J. Med. Sci. 5:125–127.PubMedGoogle Scholar
  82. 81.
    Flamm, H., 1966, Some considerations concerning the pathogenesis of prenatal infection, in: The Prevention of Mental Retardation Through Control of Infectious Diseases (H. C. Eichenwald, ed.), pp. 79–87, U.S. Government Printing Office, Washington, D.C.Google Scholar
  83. 82.
    Medrano, I., and Green, H., 1973, Picornavirus receptors and Picornavirus multiplication in human-mouse hybrid cell lines, Virology 54:515–524.PubMedCrossRefGoogle Scholar
  84. 83.
    Coullin, P., Bone, A., Relourcet, R., and Van-Cog, N., 1976, Permissivité de clone cellulaire hybride hommesouris à trois enterovirus: Polio II, Coxsackie B3, et echo II: Role dû chromosome humain F. 19, Pathol. Biol. (Paris) 24:195–203.Google Scholar
  85. 84.
    Gerald, P. S., and Bruns, G. A., 1978, Genetic determinants of viral susceptibility, Birth Defects 14:1–7.PubMedGoogle Scholar
  86. 85.
    Miller, D. A., Miller, O. J., Dev, V. G., Hashmi, S., Tantravahi, R., Medrano, L., and Green, H., 1974, Human chromosome 19 carries a poliovirus receptor gene, Cell 1:167–174.CrossRefGoogle Scholar
  87. 86.
    Cook, S. A., Loria, R. M., and Madge, G. E., 1982, Host factors in coxsackievirus B4 induced pancreopathy,J. Lab. Invest. 46:377–383.Google Scholar
  88. 87.
    Loria, R. M., Montgomery, L. B., and Tuttle-Fuller, N., and Gregg, H. M., 1986, Influence of diabetes mellitus heredity is associated with impaired immunity to coxsackievirus B4, Diabetes Res. Clin. Pract. 2:91–96.PubMedCrossRefGoogle Scholar
  89. 88.
    Montgomery, L. B., and Loria, R. M., 1986, Humoral immunity in hereditary and overt diabetes mellitus, Med. Virol. 12:255–268.Google Scholar
  90. 89.
    Banatvala, J. E., Bryant, J., Schernthaner, G., Borkenstein, M., Schoeber, E., Brown, D., DeSilve, L. M., Menser, M. A., and Silink, M., 1985, Coxsackie B, mumps rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia, Lancet 1:1409–1411.PubMedCrossRefGoogle Scholar
  91. 90.
    Schernthaner, G., Banatvala, J. E., Scherbaum, W.. Bryant, J., Borkstein, M., Schoeber, E., and Mayr, W. R., 1985, Coxsackie B virus specific IgM responses, complement fixing islet cell antibodies, HLA Dr antigens and C peptide secretion in insulin dependent diabetes mellitus, Lancet 2:630–632.PubMedCrossRefGoogle Scholar
  92. 91.
    Niklasson, B. S., Dobersen, M. J., Peters, C. J., Ennis, W. H., and Moller, E., 1985, An outbreak of coxsackievirus B infection followed by one case of diabetes mellitus, Scand. J. Infect. Dis. 17:15–18.PubMedCrossRefGoogle Scholar
  93. 92.
    Frisk, G., Fohlman, J., Kobbah, M., Ewald, U., Tuvemo, T., Diderholm, H., and Friman, G., 1985, High frequency of coxsackie-B-virus-specific IgM in children developing type I diabetes during a period of high diabetes morbidity, J. Med. Virol. 17:219–227.PubMedCrossRefGoogle Scholar
  94. 93.
    Huber, S. A., and Lodge, P. A., 1986, Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice, Am. J. Pathol. 122:284–91.PubMedGoogle Scholar
  95. 94.
    Schnurr, D. P., and Schmidt, N.J., 1984, Coxsackievirus B3 persistence and myocarditis in NFR nu/nu and + /nu mice, Med. Microbiol. Immunol. (Berl.) 173:1–7.CrossRefGoogle Scholar
  96. 95.
    Woodruff, J. F., 1970, The influence of quantitative post-weaning under nutrition on coxsackievirus B-3 infection of adult mice. I. Viral persistence and increased in severity of lesions,J. Infect. Dis. 121:137–163.PubMedCrossRefGoogle Scholar
  97. 96.
    Woodruff, J. F., 1970, The influence of quantitative postweaning under nutrition on coxsackievirus B-3 infection of adult mice. II. Alteration of host defenses mechanisms,J. Infect. Dis. 121:164–181.PubMedCrossRefGoogle Scholar
  98. 97.
    Feigin, R. D., Middelkamp, J. N., and Reed, C. A., 1972, Murine myocarditis due to Coxsackie B3 virus: Blood amino acid, virologic and histopathologic correlates,J. Infect. Dis. 126:574–584.PubMedCrossRefGoogle Scholar
  99. 98.
    Loria, R. M., Kibrick, S., and Broitman, S. A., 1977, Pathophysiological aspects of coxsackievirus B intestinal infection, Am. J. Clin. Nutr. 30:1876–1879.PubMedGoogle Scholar
  100. 99.
    Loria, R. M., Kibrick, S., and Madge, G., 1976, Infection in hypercholesteremic mice with coxsackievirus B,J. Infect. Dis. 133:655–662.PubMedCrossRefGoogle Scholar
  101. 100.
    Campbell, A. E., Loria, R. M., and Madge, G. E., Coxsackievirus B cardiopathy and angiopathy in the hypercholesteremic host, Atherosclerosis 31:295–306.Google Scholar
  102. 101.
    Kos, W. L., Loria, R. M., Snodgrass, M. J., Cohen, D., Thorpe, T. G., and Kaplan, A. M., 1979, Inhibition of host resistance by nutritional hypercholesteremia, Infect. Immun. 26:658–667.PubMedGoogle Scholar
  103. 102.
    Campbell, A. E., Loria, R. M., Madge, G. E., and Kaplan, A. M., Suppression of immunity of coxsackievirus by dietary hypercholesteremia, Infect. Immun. 37:307–317.Google Scholar
  104. 103.
    Gelfand, H. M., 1961, The occurrence in nature of the Coxsackie and ECHO viruses, Prog. Med. Virol. 3:193–244.PubMedGoogle Scholar
  105. 104.
    Ainbender, E., Weisinger, R. B., Hevizy, M., and Hodes, H. L., 1968, Differences in the immunoglobulin classes of polio antibody in the serum of men and women,J. Immunol. 101:92–98.PubMedGoogle Scholar
  106. 105.
    Huber, S. A., Job, L. P., and Woodruff, J. F., 1981, Sex-related differences in the pattern of coxsackievirus B-3-induced immune spleen cell cytotoxicity against virus-infected myofibers, Infect. Immun. 32:8–73.Google Scholar
  107. 106.
    Lynden, D. L., and Huber, S. A., Aggravation of coxsackievirus, group B, type 3 induced myocarditis and increase in cellular immunity to myocyte antigens in pregnant Balb/c mice and animals treated with progesterone, Cell. Immunol. 87:462–472.Google Scholar
  108. 107.
    Kilbourne, E. D., and Horsfall, F. L., Jr., 1951, Lethal infection with coxsackievirus of adult mice given cortisone, Proc. Soc. Exp. Biol. Med. 77:135–138.PubMedGoogle Scholar
  109. 108.
    Gatmaitan, B. G., Chason, J. L., and Lerner, A. M., 1970, Augmentation of virulence of murine coxsackievirus B3 myocardiopathy by exercise,J. Exp. Med. 131:121–136.CrossRefGoogle Scholar
  110. 109.
    Reyes, M. P., Thomas, J. A., Smith, F. E., and Lerner, A. M., 1982, Elevated thymocytes norepinephrine and cyclic guanosine 3′5′ monophosphate in T-lymphocytes from exercised mice with coxsackievirus B3 myocarditis, Biochem. Biophys. Res. Commun. 109:704–708.PubMedCrossRefGoogle Scholar
  111. 110.
    Jamal, G. A., and Hansen, S., 1985, Electrophysiological studies in the post-viral fatigue syndrome,J. Neurol. Neurosurg. Psychiatry 48:691–694.PubMedCrossRefGoogle Scholar
  112. 111.
    Rezkalla, S., Khatib, G., and Khatib, R., 1986, Coxsackievirus B3 murine myocarditis: Deleterious effect of nonsteroidal anti-inflammatory agents, J. Lab. Clin. Med. 107:393–395.PubMedGoogle Scholar
  113. 112.
    Andrews, C. G., Drachman, D. B., Pestronck, A., and Narayan, O., 1984, Susceptibility of skeletal muscle to Coxsackie A2 virus infection: Effects of Botulinum toxin and denervation, Science 223:714–716.CrossRefGoogle Scholar
  114. 113.
    Kabiri, M., Basiri, E., and Kadivar, D., 1978, Potentiation of coxsackievirus B3 infection in adult mice pretreated with gold salt, J. Med. Virol. 3:125–136.PubMedCrossRefGoogle Scholar
  115. 114.
    Friedman, S. B., Ader, R., and Glasgow, L. A., 1965, Effects of psychological stress in adult mice inoculated with Coxsackie B viruses, Psychosom. Med. 2b7:361–368.Google Scholar
  116. 115.
    Schneck, L., and Berkovich, S., 1965, Effects of X-irradiation on the susceptibility of neonatal rat brain and muscle to Coxsackie B1 virus infection, Proc. Soc. Exp. Biol. Med. 118:658–661.PubMedGoogle Scholar
  117. 116.
    Cheever, F. S., 1953, Multiplication of Coxsackie virus in adult mice exposed to roentgen radiation,J. Immun. 71:431–435.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Roger M. Loria
    • 1
    • 2
  1. 1.Departments of Microbiology, Immunology, and PathologyVirginia Commonwealth UniversityRichmondUSA
  2. 2.School of Basic Health SciencesMedical College of VirginiaRichmondUSA

Personalised recommendations